Uphononongo olutsha lwezonyango ebantwini lusebenzisa isicatshulwa se-ashwagandha esisemgangathweni ophezulu, i-Witholytin, ukuvavanya imiphumo yaso emihle ekudinweni nasekuxinezelekeni.
Abaphandi bahlole ukhuseleko lwe-ashwagandha kunye nempembelelo yayo ekudinweni nasekuxinezelekeni okubonwayo kumadoda nabafazi abali-111 abasempilweni abaneminyaka engama-40-75 ubudala abanamava amanqanaba aphantsi amandla kunye noxinzelelo oluphakathi ukuya koluphezulu olubonwayo kwixesha leeveki ezili-12. Olu phononongo lusebenzise idosi ye-200 mg ye-ashwagandha kabini ngemini.
Iziphumo zibonise ukuba abathathi-nxaxheba abathatha i-ashwagandha baye bancipha kakhulu ngama-45.81% kumanqaku e-Chalder Fatigue Scale (CFS) kwihlabathi liphela kunye nokuncipha kwama-38.59% kuxinzelelo (umlinganiselo woxinzelelo olubonwayo) xa kuthelekiswa nomlinganiselo wokuqala emva kweeveki ezili-12.
Ezinye iziphumo zibonise ukuba amanqaku omzimba kwiNkqubo yoLwazi loKulinganisa iZiphumo eziBikiweyo kwiSigulana (i-PROMIS-29) anyuke (aphucukile) nge-11.41%, amanqaku engqondo kwi-PROMIS-29 (aphucukile) anciphe nge-26.30% kwaye anda nge-9 .1% xa kuthelekiswa ne-placebo. Ukuguquguquka kwesantya sentliziyo (i-HRV) kwehle nge-18.8%.
Isiphelo solu phononongo sibonisa ukuba i-ashwagandha inamandla okuxhasa indlela yokutshintsha indlela yokuphila, ukulwa nokudinwa, ukuhlaziya umzimba, nokukhuthaza i-homeostasis kunye nokulinganisela.
Abaphandi ababandakanyekayo kolu phando bathi i-ashwagandha ineengenelo ezinkulu ezinika amandla kubantu abakwiminyaka ephakathi nabadala abatyebileyo abanengxaki yoxinzelelo olukhulu kunye nokudinwa.
Kwenziwe uhlalutyo oluncinci ukuze kuhlolwe ii-biomarkers zehomoni kubathathi-nxaxheba abangamadoda nabasetyhini. Amanqanaba egazi le-testosterone yasimahla (p = 0.048) kunye nehomoni ye-luteinizing (p = 0.002) anyuswe kakhulu nge-12.87% kumadoda athatha i-ashwagandha xa kuthelekiswa neqela le-placebo.
Ngenxa yezi ziphumo, kubalulekile ukuphinda kufundwe amaqela abantu abanokuzuza ngokuthatha i-ashwagandha, njengoko iziphumo zayo zokunciphisa uxinzelelo zinokwahluka ngokuxhomekeke kwizinto ezifana nobudala, isini, imeko yesalathisi sobunzima bomzimba, kunye nezinye izinto eziguquguqukayo.
“Siyavuya kuba le ncwadi intsha idibanisa ubungqina obuxhasa iVitolitin kunye nobungqina bethu obukhulayo obubonisa ukubekwa emgangathweni kwe-USP kwe-ashwagandha extract,” ucacise watsho uSonya Cropper, usekela-mongameli oyintloko weVerdure Sciences. UCropper uyaqhubeka, “Kukho umdla okhulayo kwi-ashwagandha, i-adaptogens, ukudinwa, amandla kunye nokusebenza kwengqondo.”
I-Vitolitin yenziwe yiVerdure Sciences kwaye isasazwa eYurophu yi-LEHVOSS Nutrition, icandelo le-LEHVOSS Group.